0
Abstract: Poster Presentations |

ENDOBRONCHIAL CHEMOTHERAPY IN MALIGNANT LESIONS OF THE LUNG: REPORT OF 5 YEARS↓ EXPERIENCE FREE TO VIEW

Hamidreza Jabbardarjani, MD*
Author and Funding Information

Tracheal Disease Research Centre. NRITLD, Masih Daneshvari Hospital, Shahid Behesht, Teheran, Iran


Chest


Chest. 2008;134(4_MeetingAbstracts):p97001. doi:10.1378/chest.134.4_MeetingAbstracts.p97001
Text Size: A A A
Published online

Abstract

PURPOSE:Bronchoscopic palliative treatment is a modalitythat could reduce the symptoms in patients with inoperable lungcancer. Our interest is to study the palliative effect ofintrabronchial chemotherapy using cisplatin, in patients withinoperable lung cancers.

METHODS:Between the years of 2003 and 2008,patients with unresectable lung cancer and endobronchial lesionwere selected for tumor debulking via intrabronchial injection ofcisplatin. After flexible bronchoscopy, maximum 20mL cisplatinwith the concentration of 50 mg/100mL was injected into thebulk of the tumor through the special needle. The procedure wasperformed weekly for 4 sessions. After the end of fourth session,this procedure was done monthly. Patients were followedaccording to the symptoms, size of the involved lumen, andchanges in the shape and size of intrabronchial lesion after localchemotherapy.

RESULTS:A hundred thirty patients were studied (90 men, 40 women). All of them diagnosed with inoperable lung cancer. Accordingto the histology, they were categorized as adenocarcinoma (n=56), squamous cell carcinoma (n=43), and nonsmall celllung cancer, unspecified (n=31). At the end of the forth sessionof local chemotherapy, the involved lumen was considerablyopened (more than 25%) in 107 patients.

CONCLUSION:We suggest that intratumoral injection of cisplatincould reduce the severe symptoms of airway obstruction,hemoptysis (massive or nonmassive), and postobstructionpneumonias in patients with inoperable lung cancer and could be used for debulking of the tumor in the caseswith inoperable lung cancer.

CLINICAL IMPLICATIONS:There is no clinical implicaction.

DISCLOSURE:Hamidreza Jabbardarjani, None.

Wednesday, October 29, 2008

1:00 PM - 2:15 PM


Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543